# Intensive Versus Standard Blood Pressure Lowering to Prevent Functional Decline in Older People

> **NCT01650402** · NA · COMPLETED · sponsor: **UConn Health** · enrollment: 199 (actual)

## Conditions studied

- Hypertension, Systolic
- Cerebrovascular Disease

## Interventions

- **OTHER:** Anti-hypertensive therapy to SBP 130 mm Hg
- **OTHER:** Anti-hypertensive therapy to SBP 145 mm Hg

## Key facts

- **NCT ID:** NCT01650402
- **Lead sponsor:** UConn Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2018-10
- **Final completion:** 2018-10
- **Target enrollment:** 199 (ACTUAL)
- **Last updated:** 2020-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01650402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01650402, "Intensive Versus Standard Blood Pressure Lowering to Prevent Functional Decline in Older People". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01650402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*